Skip to main content

Table 1 Genetic and Clinical Findings in Patients with LAMA2 MD

From: Early versus late diagnosis of LAMA2 congenital muscular dystrophy: a distinct consequence

Patient

Age/Sex

Age at diagnosis

LAMA2 mutations

Initial presentation

Initial CPK level (IU/L)

Brain MRI

Clinical course and outcome

1

7 y/F

8 mo

c.7525_7528dupCTCA(p.Ser2510ThrfsTer3)/c.112 + 2 T > C

Hypotonia and feeding difficulties from early infancy

2217

At 8 mo: Abnormal periventricular and subcortical white matter signals

Mental activity and cognition were normal, but ambulation was not achieved

2

14 mo/M

1 mo after death (14 mo)

c.1583dupA(p.S529Efs*18)/c.A6931T(p.K2311X)

Hypotonia, respiratory muscle weakness, and feeding difficulties from birth

548

First (10 mo): Ventricular dilatation and myelination delay. Second (12 mo): Extensive cystic cavities and marked neuronal tissue loss in both hemispheres

OHCA twice and death from respiratory failure

  1. CPK creatine phosphokinase; F female; LAMA2 laminin alpha-2; M male; MD muscular dystrophy; Mo month; OHCA out-of-hospital cardiac arrest; y year